supported by the Open Foundation Project of Pharmacy in Zhejiang Province,China(Grant No.YKFJ2-010);the National Natural Science Foundation of Henan Province,China(Grant No.182300410312);Henan Provincial University Science and Technology Innovation Team,Department of Education of Henan Province(Grant No.19IRTSTHN001,China);Key Research Project of University,Department of Education of Henan Province(Grant No.20A350019,China);the National Science and Technology Major Project of China(Grant No.2018ZX10302205)
Dysregulation of mTORCl/mTORC2 pathway is observed in many cancers and mTORC1 inhibitors have been used clinically in many tumor types;however,the mechanism of mTORC2 in tumorigenesis is still obscure.Here,we mainly e...
supported by grants from the National Natural Science Foundation of China (no.81772471);the Qinghai Science & Technology Department Funding (2017-ZJ-709)
Resistance to radiotherapy causes non-small cell lung cancer(NSCLC)treatment failure associated with local recurrence and metastasis.Thus,understanding the radiosensitization of NSCLC cells is crucial for developing n...
This study was supported by grants from the National Natural Science Foundation of China (81071915 and 31301160) and the Tianjin Health Bureau (2011KZ107).
Aim: Previous study has shown that endometrial cancers with LKB1 inactivation are highly responsive to mTOR inhibitors. In this study we examined the effect of LKB1 gene status on mTOR inhibitor responses in non-smal...